Hisham A Badreldin
Overview
Explore the profile of Hisham A Badreldin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Badreldin H, Alsuhebany N, Alfehaid L, Alzahrani M, Aldoughaim M, Alrajhi A, et al.
Cardiooncology
. 2024 Dec;
10(1):93.
PMID: 39736669
Introduction: The evolving field of oncology necessitates effective management of cancer-related cardiovascular diseases. In Saudi Arabia, the incidence of cancer is rising, and there is a critical need for cardio-oncology...
2.
Alrashed M, Alyousef A, Badreldin H, Bin Saleh K, Al Harbi S, Albekairy A, et al.
Diseases
. 2024 Dec;
12(12.
PMID: 39727662
Background: Acetaminophen is generally considered safe when used according to the recommended guidelines. Consumption in excessive doses can lead to severe liver damage and, in critical cases, may even result...
3.
Al Raddadi S, Almutairi M, Alaamer K, Alsalman A, Albalawi M, Almeshary M, et al.
Drug Healthc Patient Saf
. 2024 Oct;
16:117-124.
PMID: 39372487
Background: Sacubitril/valsartan (S/V) is used in managing heart failure with reduced ejection fraction (HFrEF), reducing morbidity and mortality while improving symptoms and prognosis. This study aims to evaluate the effectiveness...
4.
Alfehaid L, Abdallah G, Kothari S, Nguyen K, Alsuhebany N, Badreldin H, et al.
Int J Cardiol
. 2024 Aug;
417:132495.
PMID: 39216749
Objective: The objective of this study was to compare the effectiveness and safety of anti-Xa-guided management versus aPTT-guided management of intravenous (IV) unfractionated heparin (UFH) in patients with a durable...
5.
Al Sulaiman K, Aljuhani O, Alkofide H, Aljohani M, Badreldin H, Al Harbi M, et al.
Thromb J
. 2024 May;
22(1):43.
PMID: 38778323
Background: Recent guidelines recommend using direct oral anticoagulants (DOACs) as first-line agents in patients with non-valvular atrial fibrillation (NVAF). Research is currently investigating the use of Apixaban in underweight patients,...
6.
Badreldin H, Alsuhebany N, Alzahrani M, Alshehri A, Aldoughaim M, Alqifari S, et al.
Curr Res Pharmacol Drug Discov
. 2024 Mar;
6:100179.
PMID: 38545505
Direct Oral Anticoagulants (DOACs) have revolutionized the treatment of thromboembolic disorders, offering targeted, effective, and safer alternatives to traditional anticoagulants like heparins and vitamin K antagonists (VKAs). Despite their benefits,...
7.
Aljuhani O, Korayem G, Altebainawi A, AlMohammady D, Alfahed A, Altebainawi E, et al.
BMC Infect Dis
. 2024 Feb;
24(1):189.
PMID: 38350878
Background: Dexamethasone usually recommended for patients with severe coronavirus disease 2019 (COVID-19) to reduce short-term mortality. However, it is uncertain if another corticosteroid, such as methylprednisolone, may be utilized to...
8.
Badreldin H, Korayem G, Alenazy B, Aljohani M, Alshaya O, Al Sulaiman K, et al.
Medicine (Baltimore)
. 2023 Dec;
102(51):e36699.
PMID: 38134075
Despite the demonstrated advantages of angiotensin receptor/neprilysin inhibitors in the management of heart failure, the pivotal Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure (PARADIGM-HF) trial, which explored this class of...
9.
Alowais S, Bosaeed M, Bin Saleh K, AlQahtani H, Selimovic N, Ahmed H, et al.
Medicine (Baltimore)
. 2023 Oct;
102(43):e35464.
PMID: 37904424
Rationale: Management of coronavirus disease 2019 (COVID-19) has been the subject of extensive research and study, leading to the development of strategies and treatments. Nonetheless, there remains a dearth of...
10.
Bin Saleh K, Badreldin H, Alqahtani T, Alsuhebany N, Alowais S, Al Sulaiman K, et al.
J Infect Public Health
. 2023 Oct;
16(12):1989-1993.
PMID: 37879151
Background: During the COVID-19 pandemic, countries around the world implemented various interventions to manage the spread of respiratory illnesses, including influenza. However, there is a lack of studies that have...